Mizuho began coverage on shares of CRISPR Therapeutics (NASDAQ:CRSP – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The firm issued a buy rating and a $82.00 price objective on the stock. A number of other brokerages have also recently weighed in on CRSP. Needham & Company LLC reiterated a […]
Stock analysts at Mizuho started coverage on shares of CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) in a report released on Tuesday, FlyOnTheWall reports. The brokerage set a “buy” rating on the stock. CRSP has been the subject of a number of other research reports. Morgan Stanley boosted their price objective on shares of CRISPR […]
Patriot Financial Group Insurance Agency LLC lifted its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 3.3% in the second quarter, HoldingsChannel reports. The fund owned 26,535 shares of the company’s stock after buying an additional 851 shares during the period. Patriot Financial Group Insurance Agency LLC’s holdings in CRISPR Therapeutics […]
Patriot Financial Group Insurance Agency LLC increased its stake in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 3.3% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 26,535 shares of the company’s stock after acquiring an additional 851 shares during the period. Patriot Financial […]